Cargando…
Correction: Oral antiviral treatments for COVID-19: opportunities and challenges
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510311/ https://www.ncbi.nlm.nih.gov/pubmed/36149599 http://dx.doi.org/10.1007/s43440-022-00410-y |
_version_ | 1784797415964934144 |
---|---|
author | Rahmah, Laila Abarikwu, Sunny O. Arero, Amanuel Godana Essouma, Mickael Jibril, Aliyu Tijani Fal, Andrzej Flisiak, Robert Makuku, Rangarirai Marquez, Leander Mohamed, Kawthar Ndow, Lamin Zarębska-Michaluk, Dorota Rezaei, Nima Rzymski, Piotr |
author_facet | Rahmah, Laila Abarikwu, Sunny O. Arero, Amanuel Godana Essouma, Mickael Jibril, Aliyu Tijani Fal, Andrzej Flisiak, Robert Makuku, Rangarirai Marquez, Leander Mohamed, Kawthar Ndow, Lamin Zarębska-Michaluk, Dorota Rezaei, Nima Rzymski, Piotr |
author_sort | Rahmah, Laila |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9510311 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-95103112022-09-26 Correction: Oral antiviral treatments for COVID-19: opportunities and challenges Rahmah, Laila Abarikwu, Sunny O. Arero, Amanuel Godana Essouma, Mickael Jibril, Aliyu Tijani Fal, Andrzej Flisiak, Robert Makuku, Rangarirai Marquez, Leander Mohamed, Kawthar Ndow, Lamin Zarębska-Michaluk, Dorota Rezaei, Nima Rzymski, Piotr Pharmacol Rep Correction Springer International Publishing 2022-09-23 2022 /pmc/articles/PMC9510311/ /pubmed/36149599 http://dx.doi.org/10.1007/s43440-022-00410-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Correction Rahmah, Laila Abarikwu, Sunny O. Arero, Amanuel Godana Essouma, Mickael Jibril, Aliyu Tijani Fal, Andrzej Flisiak, Robert Makuku, Rangarirai Marquez, Leander Mohamed, Kawthar Ndow, Lamin Zarębska-Michaluk, Dorota Rezaei, Nima Rzymski, Piotr Correction: Oral antiviral treatments for COVID-19: opportunities and challenges |
title | Correction: Oral antiviral treatments for COVID-19: opportunities and challenges |
title_full | Correction: Oral antiviral treatments for COVID-19: opportunities and challenges |
title_fullStr | Correction: Oral antiviral treatments for COVID-19: opportunities and challenges |
title_full_unstemmed | Correction: Oral antiviral treatments for COVID-19: opportunities and challenges |
title_short | Correction: Oral antiviral treatments for COVID-19: opportunities and challenges |
title_sort | correction: oral antiviral treatments for covid-19: opportunities and challenges |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510311/ https://www.ncbi.nlm.nih.gov/pubmed/36149599 http://dx.doi.org/10.1007/s43440-022-00410-y |
work_keys_str_mv | AT rahmahlaila correctionoralantiviraltreatmentsforcovid19opportunitiesandchallenges AT abarikwusunnyo correctionoralantiviraltreatmentsforcovid19opportunitiesandchallenges AT areroamanuelgodana correctionoralantiviraltreatmentsforcovid19opportunitiesandchallenges AT essoumamickael correctionoralantiviraltreatmentsforcovid19opportunitiesandchallenges AT jibrilaliyutijani correctionoralantiviraltreatmentsforcovid19opportunitiesandchallenges AT falandrzej correctionoralantiviraltreatmentsforcovid19opportunitiesandchallenges AT flisiakrobert correctionoralantiviraltreatmentsforcovid19opportunitiesandchallenges AT makukurangarirai correctionoralantiviraltreatmentsforcovid19opportunitiesandchallenges AT marquezleander correctionoralantiviraltreatmentsforcovid19opportunitiesandchallenges AT mohamedkawthar correctionoralantiviraltreatmentsforcovid19opportunitiesandchallenges AT ndowlamin correctionoralantiviraltreatmentsforcovid19opportunitiesandchallenges AT zarebskamichalukdorota correctionoralantiviraltreatmentsforcovid19opportunitiesandchallenges AT rezaeinima correctionoralantiviraltreatmentsforcovid19opportunitiesandchallenges AT rzymskipiotr correctionoralantiviraltreatmentsforcovid19opportunitiesandchallenges |